Contents
Issue 134 • September 2023
In association with
In Depth
UK life sciences grapple with the job market’s digital dilemma
Telemedicine struggles to overcome diversity challenges in dermatology trials
Cancer treatment uncertainty: European nations struggle with drug shortages
From Europe to Latin America: Driving access to affordable biosimilars
Q&A: The Henrietta Lacks lawsuit confronts biotech's view on ethics
Generative AI has the potential to revolutionise drug discovery
European PFAS ban would burden drug companies and packagers
